Patient Management Stage
| The NCCN Clinical Practice Guidelines in Oncology and the International Myeloma Working Group recommend the use of serum free light chain assays (Freelite®) in the initial diagnostic workup of multiple myeloma and related disorders.1,2 | ![]() |
- Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Multiple Myeloma V.1.2012. © 2011 National Comprehensive Cancer Network, Inc. All rights reserved.
- Dispenzieri, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009; 23:215-224








